Yes, shorting is often used as an excuse for any penny stock's poor performance. RXMD's short interest isn't dire, at 468,188 shares. But since the stock is on the Threshold List, obviously it does have a problem with fails to deliver of some kind.
As I said before, management might to better to talk to FINRA about that than to put out press releases.
He's the link to FINRA's bi-monthly short interest report:
News 
Market Data 
Discover 
